New aspartame data to be presented at Mount Sinai School of Medicine in NYC, USA
A second study conducted by the European Ramazzini Foundation (ERF) confirms the carcinogenicity of aspartame. The results of this study will be presented April 23, 2007 at the Mount Sinai Medical School of New York, where ERF Scientific Director Morando Soffritti will receive the third Irving J. Selikoff Award. [vedi testo completo per l'italiano]
Aspartame is an artificial sweetener consumed by hundreds of millions of people worldwide. It is used in over 6,000 diet products including soft drinks, chewing gum, candy, desserts, yogurt as well as in pharmaceuticals, in particular, syrups and antibiotics for children. In 2005, the European Ramazzini Foundation published important experimental data demonstrating the carcinogenicity of aspartame. These data demonstrated for the first time that aspartame is a carcinogenic agent, inducing various types of malignant tumors in rats, even at dose levels currently considered acceptable for humans.
As soon as carcinogenic effects were perceived during this first study, the ERF began a second long term experiment, administering aspartame at low doses in feed to rats beginning during fetal life.
In a world exclusive, Italian news station TG2 announced on April 13th that the European Ramazzini Foundation will present the results of this second study at the Mount Sinai School of Medicine at the end of April when Scientific Director Dr. Morando Soffritti will receive the third Irving J. Selikoff Award. The news story may be viewed at: http://www.raiclicktv.it/raiclickpc/secure/list_content_tg.srv?id=1986#